Mackenzie Maximum Diversification Developed Europe Index ETF (TSX: MEU)
Canada
· Delayed Price · Currency is CAD 23.01
-0.21 (-0.90%)
May 13, 2024, 2:18 PM EDT
3.42% (1Y)
| Assets | 6.95M |
| Expense Ratio | 0.82% |
| PE Ratio | 13.87 |
| Dividend (ttm) | 0.82 |
| Dividend Yield | 3.57% |
| Ex-Dividend Date | Mar 18, 2024 |
| Payout Frequency | Quarterly |
| Payout Ratio | 49.56% |
| 1-Year Return | +3.42% |
| Volume | 8 |
| Open | 23.01 |
| Previous Close | 23.22 |
| Day's Range | 23.01 - 23.01 |
| 52-Week Low | 19.82 |
| 52-Week High | 23.39 |
| Beta | 0.87 |
| Holdings | 283 |
| Inception Date | Sep 7, 2016 |
About MEU
Mackenzie Maximum Diversification Developed Europe Index ETF (MEU) is an exchange-traded fund that trades on the Toronto Stock Exchange in Canada. It tracks an index of developed-Europe equity securities, filtered through a proprietary ESG criteria, and optimized to maximize a measure of diversification.
Asset Class Equity
Category Total Market
Stock Exchange TSX
Ticker Symbol MEU
Provider Mackenzie
Index Tracked TOBAM Maximum Diversification Developed Europe Index - EUR
Performance
MEU had a total return of 3.42% in the past year. Since the fund's inception, the average annual return has been 1.87%, including dividends.
Top 10 Holdings
16.70% of assets| Name | Symbol | Weight |
|---|---|---|
| Cash | n/a | 2.67% |
| Banco de Sabadell SA | SAB.MC | 1.82% |
| AstraZeneca PLC | AZN.L | 1.68% |
| Bank of Ireland Group PLC | BIRG.IR | 1.58% |
| UCB SA | UCB.BR | 1.57% |
| Telefonica SA | TEF.MC | 1.52% |
| Novo Nordisk A/S Class B | NOVO B.CO | 1.50% |
| Koninklijke Ahold Delhaize NV | AD.AS | 1.46% |
| GSK PLC | GSK.L | 1.45% |
| Sanofi SA | SAN.PA | 1.45% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 18, 2024 | 0.05269 CAD | n/a |
| Dec 18, 2023 | 0.27253 CAD | n/a |
| Sep 18, 2023 | 0.13345 CAD | n/a |
| Jun 19, 2023 | 0.36344 CAD | n/a |
| Mar 20, 2023 | 0.01438 CAD | Mar 28, 2023 |
| Dec 19, 2022 | 0.06371 CAD | Dec 29, 2022 |